Patients treated with peritoneal dialysis (PD) are at risk for development of ultrafiltration failure and peritonitis. The relative unphysiologic composition of the currently used peritoneal dialysis fluids (PDF) is a major cause for the development of morphologic changes of the peritoneal membrane such as fibrosis and new vessel formation, ultimately resulting in ultrafiltration failure. In recent years, a major research focus has become the development of new and improved PDF. Typically, the first phase of biocompatibility testing of new PDF involves in vitro testing, using cell culture systems such as primary mesothelial cells or peritoneal macrophages. In vivo studies using animal models permit the analysis of biocompatibility under conditions that allow for cell-to-cell interactions and dynamic changes in solution composition that more closely mimic the clinical situation. In this paper, we will review the applicability of a peritoneal exposure model in the rat to study PDF biocompatibility-related issues.
Introduction
It is now widely recognized that several constituents of conventionally used peritoneal dialysis fluids (PDFs) are bioincompatible and play a role in the development of a chronic inflammatory condition in the peritoneal cavity of peritoneal dialysis (PD) patients.
The presence of supra-physiological glucose concentrations, glucose degradation products (GDPs), acid pH as well as high lactate concentrations contribute to the morphological changes occurring in the peritoneal membrane which ultimately can result in ultrafiltration (UF) failure [1, 2] . In addition to these factors, the presence of a chronically indwelling catheter as well as the instillation of large volumes of fluid per se might contribute to the observed peritoneal changes. In recent years, major efforts have been made to develop new and improved PDF resulting in the production of commercially available PDF containing alternative osmotic agents (amino-acid-based and glucose polymer-based PDFs) or PDFs with a different composition (neutral pH, lower GDP, different buffer). In the following overview, we will summarize information about biocompatibility of different PDFs studied in a pre-clinical peritoneal exposure model in the rat.
Animal model
Biocompatibility can be studied in vitro employing cell culture systems that can provide information about individual PDF components on cellular functions. However, extrapolation from these data to in vivo effects is difficult. Thus, the application of animal models can provide information about peritoneal response to PDF exposure and closely mimic dynamic changes in solution composition during PD [3] .
In our animal model, a peritoneal catheter (13 cm in length) is implanted into the rat peritoneal cavity and tunnelled subcutaneously to the neck region, where it is connected to a mini vascular access port. No omentectomy is performed. Uraemia is not present. During a 1-week recovery period rats received daily treatment with 2 ml of saline solution containing 1 U/ml of heparin. After this period, 10 ml of the experimental solution is injected daily for a period of 5-10 weeks. Neither antibiotics nor heparin are added to the solution. At the end of the infusion period, a peritoneal equilibrium test (PET) is performed followed by sampling of peritoneal tissues. Although our model does not exactly mimic the clinical situation, we have shown similar functional and morphological changes as observed in PD patients, and thus represents a powerful tool that allows the study of peritoneal changes upon chronic exposure to PDF.
Peritoneal changes by the conventional PDF
The conventional PDF is a glucose-containing, lactatebuffered (40 mM) solution with pH 5.2 and GDPs that are formed during sterilization. Daily exposure of rat peritoneum for a period of 5-10 weeks of 10 ml dianeal 3.86% causes several morphological and functional alterations [4] [5] [6] .
The major histological changes observed were an increase in submesothelial vessel density and fibrosis, focal presence of granulation tissue, mesothelial damage and regeneration along with endothelial activation. In the omentum, this process is associated with an increase in number and size of the milky spot. Milky spots are local aggregates of leucocytes (mainly macrophages), confirming the induction of an inflammatory response in the peritoneal cavity. All these peritoneal changes are a part of a coordinated chronic peritoneal healing response pathway. This response is largely reversible in character, as demonstrated by the reduction of most PDF-induced morphological alterations after 3 months of peritoneal rest in our animal model [7] . Finally, the functional counterpart of all these morphological alterations were clear in data from a 1.5 h PET test, as we observed a reduction of net ultrafiltration volume by 30% and an increased glucose absorption by 25% after conventional PDF treatment for 5 weeks.
In a separate experiment, we evaluated the impact of uraemia on the PDF-induced peritoneal changes by combining sub-total nephrectomy with our chronic peritoneal exposure model. The major conclusion was that besides an increased AGE-accumulation in newly formed blood vessels, uraemia barely worsened peritoneal changes [8] .
How to improve PDF solutions?
While the major bioincompatibility factors have been recognized in vitro [9] [10] , less is known about their actions in the peritoneal cavity and their relative contribution to morphological and functional alterations in vivo. In order to investigate this specific topic, we performed a series of experiments (summarized in Table 1 ) in which we tested the relative contribution of glucose, GDP, buffering system and fluid acidity on peritoneal alterations.
GDP reduction
The rate of GDP production during heat sterilization of conventional PDF is pH dependent. At low pH, less GDP are generated. Therefore, multichamber bags for dialysis solutions have been developed in which glucose is separated from the other solution components. Compared with conventional PDF, the new solutions are characterized by similar concentration of glucose, but with a lower level of GDP and more physiological pH. Lactate concentration may differ and are sometimes partially replaced by bicarbonate (physioneal). In our in vivo model, we evaluated whether 9-10 weeks physioneal exposure was able to prevent the peritoneal morphological alterations we described after chronic dianeal treatment [4] . Angiogenesis and milky spot response in omental tissues were clearly reduced in physioneal-treated animals in comparison with dianeal. In addition, a reduction in submesothelial extracellular matrix (ECM) thickness in parietal peritoneum was found upon physioneal treatment. Furthermore, we reported that ex vivo bacterial killing capacity significantly improved in lactate-bicarbonate PDF treated animals. These results demonstrated that physioneal is more biocompatible than conventional PDF, which was corroborated by others as well [11] .
In a separate experiment, conventional PDF was supplemented with aminoguanidine, a compound that scavenges reactive GDPs and prevents AGE accumulation. Interestingly, omental angiogenesis, fibrosis of parietal and visceral peritoneum as well as endothelial 
Peritoneal changes are indicated from -(no changes), þ (weak) to þþþ (very strong), ?: not known. GDP content is indicated from -(not present) to þþþ (much); downward arrow: reduced compared to Dianeal.
activation were largely prevented, emphasizing the role of GDPs and AGEs in peritoneal worsening [14] . Next, we evaluated the sole contribution of GDP on the peritoneal membrane. To this end, during 8-10 weeks animals received daily filter-sterilized dianeal vs normal heat-sterilized dianeal, the difference being the absence or presence of GDP. These groups were compared with a control group receiving the lactate buffer without glucose and GDP. The pH of all the three solutions was 5.2. Analysis of peritoneal tissues and cells showed a reduced milky spot response in the filter-sterilized PDF group compared with the heat-sterilized PDF group. Likewise, a reduction of Fc-receptor positive cells in the peritoneal cavity, along with an improvement of mesothelial morphology was observed in the filter PDF group. From these data, we concluded that GDP per se affected immunological parameters and mesothelial cell integrity, whereas angiogenesis and fibrosis were related to other factors, at least in an acid lactate environment [5] .
Other PDF factors
Comparison of chronic peritoneal exposure to filtersterilized PDF or the corresponding lactate buffer (difference being the glucose content) showed that peritoneal fibrosis was absent in the lactate buffer group, however, clearly present in the filter PDF group, thus mainly being glucose-driven. Angiogenesis was partly induced in the lactate buffer-treated group, and clearly strengthened in the filter-sterilized PDF group, thus showing that new vessel formation is partly related to lactate buffer, and partly related to the presence of glucose [5] . In recent experiments, we noticed that PDF acidity seems not to play a major role in peritoneal damage, probably related to the high capacity of the peritoneum to immediately buffer the injected solution to physiological pH. In contrast to this, we speculate the buffering system (acid lactate vs neutral lactate/bicarbonate) to be involved in the peritoneal response to PDF exposure [15] .
Amino acids
Replacement of glucose by other osmotic agents, such as amino acids has been considered to be an effective strategy to reduce the bioincompatibility of the conventional glucose-containing PDFs [12] . Rats chronically exposed to amino acid-PDF (nutrineal) [13] manifested a significantly reduced milky spot response in the omentum, reduced angiogenesis in the parietal peritoneum and reduced fibrosis both in mesentery and parietal peritoneum in comparison with conventional PDF-treated animals. Importantly, amino acid-PDF treatment reduced the PDF-induced rolling leucocyte level in mesenteric venules in comparison with the conventional PDF-treated animals. In conclusion, compared with conventional PDF, rats exposed to amino acid-PDF treatment had a better preservation of peritoneal morphology and microcirculation.
Conclusion
The peritoneal exposure model in the rat is a useful pre-clinical tool to evaluate effects of PDF on peritoneal physiology. The model resembles many characteristics of the human peritoneum under PD conditions even in the absence of uraemia and the absence of multiple daily fluid exchanges. The model allows evaluation of bio(in)compatibility of fluids and might reveal mediators/pathways involved in peritoneal damage upon chronic PDF exposure. As we have shown, major improvements in biocompatibility have been achieved by new PDFs by replacing glucose as osmotic agent, changing the buffer system and preventing the production of GDPs. On the other hand, our findings indicate that part of the peritoneal response is not related to PDF composition, but also chronic volume exposure, the presence of a long-term indwelling catheter and probably uraemia. For these reasons we speculate that further achievements in preventing peritoneal worsening might be obtained by pharmacological down-modulation of the chronic peritoneal healing response pathway.
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